Kester Capital announces refinancing of Frontier Medical
16 December 2014
Kester Capital is pleased to announce the refinancing of Frontier Medical on the back of a continued period of profit growth and the succesful transition to the new management team. RBS provided a new term loan the proceeds of which were used to repay 50% of the initial investment.
Cameron Crockett or Jeniv Shah / +44 20 3747 5700
Simon Jackson / email@example.com
About Kester Capital
Kester Capital is a mid-market UK private equity firm investing in businesses with an enterprise value of £10-50 million. It was established in 2007 as Greenhill Capital Partners Europe, the European private equity arm of Greenhill & Co.
About Frontier Medical
Frontier is a leading manufacturer and supplier of pressure area care and infection control products to healthcare providers in the UK and internationally. Frontier’s portfolio of highly regarded brands includes: Repose, a range of leading pressure area care devices; Sharpsafe, premium quality sharps disposal containers; and eXchange, specialist harm reduction products and services. Pressure area care and infection control have emerged as areas of serious concern for healthcare providers across the world and Frontier has an enviable track record of helping its customers deal with these growing issues both in the UK and overseas.